- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 9.36M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $34.22M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $37.9M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.2M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.97M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $47.02M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $48.42M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $38.95M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $43.83M |
| Revenue | Q1 2025 · Mar 31, 2025 | $2.57M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.14M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 1.52M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $836K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$30.45M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $29.8M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $57.09M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$20.24 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$20.24 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.82M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $21.96M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$30.7M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$29.67M |